Study Evaluating The Pharmacokinetics (PK) And Safety Of Bosutinib In Subjects With Liver Disease And In Healthy Subjects
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the pharmacokinetics of bosutinib and the safety and
tolerability of bosutinib in healthy subjects and subjects with liver disease.